S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Other Current Liabilities
kr1.1m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Other Current Liabilities
kr178.8B
CAGR 3-Years
32%
CAGR 5-Years
26%
CAGR 10-Years
21%
H Lundbeck A/S
CSE:HLUN A
Other Current Liabilities
kr3.5B
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Other Current Liabilities
kr216m
CAGR 3-Years
-20%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Other Current Liabilities?
Other Current Liabilities
1.1m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Other Current Liabilities amounts to 1.1m DKK.

What is Stenocare A/S's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
12%

Over the last year, the Other Current Liabilities growth was -27%.

Back to Top